AbstractEmerging markets have been recognized as the key growth driver of the global pharmaceutical market. They have thus received increasing attention from almost all drug companies around the world. In addition to the attraction of the fast growing pharmaceutical market, the availability of a variety of outsourcing services at relatively low cost with increasing service capability and improved quality, is also attracting drug companies from all over the world to look for the outsourcing or collaboration opportunities in these countries, in particular China and India. Currently, a large number of drug companies from all over the world are aggressively looking for partnerships with local companies or research organizations. Meanwhile, to meet the high demand by the global drug companies and to position them well in these fast growing pharma outsourcing markets, almost all world major CROs and CMOs have made significant investments in these emerging countries. This presentation will discuss in detail a series of new outsourcing strategies currently pursued by the global drug companies in these key emerging outsourcing countries and the strengths and weakness of the local service providers.